(6S,9S,15S,18S,21S,24S,27S,36S)-24-((1H-indol-3-yl)methyl)-27-((S)-2-acetamido-3-(4-hydroxyphenyl)propanamido)-1-amino-21-(2-amino-2-oxoethyl)-6-((S)-1-amino-3-(4-hydroxyphenyl)-1-oxopropan-2-ylcarbamoyl)-15-benzyl-18-(hydroxymethyl)-1-imino-9-isobutyl-8,11,14,17,20,23,26,33-octaoxo-36-palmitamido-2,7,10,13,16,19,22,25,32-nonaazaheptatriacontan-37-oic acid

ID: ALA3422514

Chembl Id: CHEMBL3422514

PubChem CID: 118735683

Max Phase: Preclinical

Molecular Formula: C88H128N18O19

Molecular Weight: 1742.10

Molecule Type: Small molecule

Names and Identifiers

Canonical SMILES:  CCCCCCCCCCCCCCCC(=O)N[C@@H](CCC(=O)NCCCC[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(C)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)C(=O)O

Standard InChI:  InChI=1S/C88H128N18O19/c1-5-6-7-8-9-10-11-12-13-14-15-16-20-32-76(113)98-66(87(124)125)41-42-75(112)93-43-24-23-30-64(100-83(120)70(97-55(4)108)48-58-35-39-61(110)40-36-58)81(118)104-71(49-59-51-95-63-29-22-21-28-62(59)63)84(121)105-72(50-74(89)111)85(122)106-73(53-107)86(123)103-69(47-56-26-18-17-19-27-56)79(116)96-52-77(114)99-68(45-54(2)3)82(119)101-65(31-25-44-94-88(91)92)80(117)102-67(78(90)115)46-57-33-37-60(109)38-34-57/h17-19,21-22,26-29,33-40,51,54,64-73,95,107,109-110H,5-16,20,23-25,30-32,41-50,52-53H2,1-4H3,(H2,89,111)(H2,90,115)(H,93,112)(H,96,116)(H,97,108)(H,98,113)(H,99,114)(H,100,120)(H,101,119)(H,102,117)(H,103,123)(H,104,118)(H,105,121)(H,106,122)(H,124,125)(H4,91,92,94)/t64-,65-,66-,67-,68-,69-,70-,71-,72-,73-/m0/s1

Standard InChI Key:  NLWSVGMVMYIQCO-YVZHOSTESA-N

Alternative Forms

1. Parent:

   

   ALA3422514

   ---

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 1742.10

Molecular Weight (Monoisotopic): 1740.9603

AlogP: ┄

#Rotatable Bonds: ┄

Polar Surface Area: ┄

Molecular Species: ┄

HBA: ┄

HBD: ┄

#RO5 Violations: ┄

HBA (Lipinski): ┄

HBD (Lipinski): ┄

#RO5 Violations (Lipinski): ┄

CX Acidic pKa: ┄

CX Basic pKa: ┄

CX LogP: ┄

CX LogD: ┄

Aromatic Rings: ┄

Heavy Atoms: ┄

QED Weighted: ┄

Np Likeness Score: ┄

References

1. Beltramo M, Robert V, Galibert M, Madinier JB, Marceau P, Dardente H, Decourt C, De Roux N, Lomet D, Delmas AF, Caraty A, Aucagne V..  (2015)  Rational design of triazololipopeptides analogs of kisspeptin inducing a long-lasting increase of gonadotropins.,  58  (8): [PMID:25811530] [10.1021/jm5019675]

Source

Source(1):

• Scientific Literature